60 related articles for article (PubMed ID: 19544302)
1. Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships.
Lu Y; Li CM; Wang Z; Ross CR; Chen J; Dalton JT; Li W; Miller DD
J Med Chem; 2009 Mar; 52(6):1701-11. PubMed ID: 19243174
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).
Rai G; Brimacombe KR; Mott BT; Urban DJ; Hu X; Yang SM; Lee TD; Cheff DM; Kouznetsova J; Benavides GA; Pohida K; Kuenstner EJ; Luci DK; Lukacs CM; Davies DR; Dranow DM; Zhu H; Sulikowski G; Moore WJ; Stott GM; Flint AJ; Hall MD; Darley-Usmar VM; Neckers LM; Dang CV; Waterson AG; Simeonov A; Jadhav A; Maloney DJ
J Med Chem; 2017 Nov; 60(22):9184-9204. PubMed ID: 29120638
[TBL] [Abstract][Full Text] [Related]
3. Revealing the Pharmacophore of Ipomoeassin F through Molecular Editing.
Zong G; Aljewari H; Hu Z; Shi WQ
Org Lett; 2016 Apr; 18(7):1674-7. PubMed ID: 26998757
[TBL] [Abstract][Full Text] [Related]
4. Exploiting Vector Pattern Diversity of Molecular Scaffolds for Cheminformatics Tasks in Drug Discovery.
Dolciami D; Ziolek RM; Davies DW; Carter M; Mok NY; Sherhod R
J Chem Inf Model; 2024 Mar; 64(6):1966-1974. PubMed ID: 38437714
[TBL] [Abstract][Full Text] [Related]
5. From SAR Diagnostics to Compound Design: Development Chronology of the Compound Optimization Monitor (COMO) Method.
Yonchev D; Vogt M; Bajorath J
Mol Inform; 2020 Dec; 39(12):e2000046. PubMed ID: 32282989
[TBL] [Abstract][Full Text] [Related]
6. Efficient Synthesis of Thiazole-Fused Bisnoralcohol Derivatives as Potential Therapeutic Agents.
Roy S; Raj Kc H; Adhikary S; Erickson AN; Alam MA
ACS Omega; 2024 Jun; 9(22):23283-23293. PubMed ID: 38854539
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of aminothiazole derivatives against the fungal pathogens Histoplasma capsulatum and Cryptococcus neoformans.
Khalil A; Edwards JA; Rappleye CA; Tjarks W
Bioorg Med Chem; 2015 Feb; 23(3):532-47. PubMed ID: 25543205
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides, a new tubulin inhibitor chemotype.
Krasavin M; Sosnov AV; Karapetian R; Konstantinov I; Soldatkina O; Godovykh E; Zubkov F; Bai R; Hamel E; Gakh AA
Bioorg Med Chem Lett; 2014 Sep; 24(18):4477-4481. PubMed ID: 25155551
[TBL] [Abstract][Full Text] [Related]
9. Identification of diaryl 5-amino-1,2,4-oxadiazoles as tubulin inhibitors: the special case of 3-(2-fluorophenyl)-5-(4-methoxyphenyl)amino-1,2,4-oxadiazole.
Gakh AA; Sosnov AV; Krasavin M; Nguyen TL; Hamel E
Bioorg Med Chem Lett; 2013 Mar; 23(5):1262-8. PubMed ID: 23385208
[TBL] [Abstract][Full Text] [Related]
10. Discovery and SAR exploration of N-aryl-N-(3-aryl-1,2,4-oxadiazol-5-yl)amines as potential therapeutic agents for prostate cancer.
Krasavin M; Rufanov KA; Sosnov AV; Karapetian R; Godovykh E; Soldatkina O; Lavrovsky Y; Gakh AA
Chem Cent J; 2010 Mar; 4():4. PubMed ID: 20214785
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer.
Gududuru V; Hurh E; Dalton JT; Miller DD
J Med Chem; 2005 Apr; 48(7):2584-8. PubMed ID: 15801848
[TBL] [Abstract][Full Text] [Related]
12. Anticancer Potential of Thiazole Derivatives: A Retrospective Review.
Jain S; Pattnaik S; Pathak K; Kumar S; Pathak D; Jain S; Vaidya A
Mini Rev Med Chem; 2018; 18(8):640-655. PubMed ID: 29173166
[TBL] [Abstract][Full Text] [Related]
13. Synthetic and Medicinal Perspective of Fused-Thiazoles as Anticancer Agents.
Pawar S; Kumar K; Gupta MK; Rawal RK
Anticancer Agents Med Chem; 2021; 21(11):1379-1402. PubMed ID: 32723259
[TBL] [Abstract][Full Text] [Related]
14. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer.
Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA
Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer.
Gududuru V; Hurh E; Dalton JT; Miller DD
Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213
[TBL] [Abstract][Full Text] [Related]
16. 2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity.
Popsavin M; Spaić S; Svircev M; Kojić V; Bogdanović G; Popsavin V
Bioorg Med Chem Lett; 2006 Oct; 16(20):5317-20. PubMed ID: 16908146
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
